抗Human MYSM1 抗体:
抗Mouse (Murine) MYSM1 抗体:
抗Rat (Rattus) MYSM1 抗体:
Human Polyclonal MYSM1 Primary Antibody for EIA, FACS - ABIN953592
Zhu, Zhou, Wang, Puc, Ohgi, Erdjument-Bromage, Tempst, Glass, Rosenfeld: A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. in Molecular cell 2007
Show all 4 Pubmed References
differentiation of B cells to plasma cells was inhibited after the overexpression of MYSM1
Data indicate a pathway MYSM1/miR-150/FLT3 that inhibits proliferation of B1a cells, which may be involved in the pathogenesis of systemic lupus erythematosus (SLE).
this study shows that MYSM1 deficiency is associated with developmental aberrations, progressive bone marrow failure with myelodysplastic features, and increased susceptibility to genotoxic stress
data suggested that expression of MYSM1 was associated with the progression of CRC and might be a potential biomarker for clinical prognosis
An in vivo genetic reversion highlights the crucial role of MYSM1 in human hematopoiesis and lymphocyte differentiation
the biallelic truncation of MYSM1 likely represents the cause of an inherited bone marrow failure syndrome in two siblings
The SWIRM structure of human MYb-like, Swirm and Mpn domain-containing protein-1 (MYSM1), is reported.
The identification of histone H2A deubiquitinase (2A-DUB, or KIAA1915/MYSM1) specific for monoubiquitinated H2A (uH2A) that helps in delineating a strategy for specific regulatory pathways of gene activation, is reported.
This study provides a complete overview of the polyubiquitins in NOD2:RIP2 signaling and reveal MYSM1 as a central negative regulator restricting these polyubiquitins to prevent excessive inflammation.
Mysm1 is a critical epigenetic regulator of epidermal development and ESC specification through interference with p53-mediated apoptosis and cell cycle inhibition-and potentially modification of p63-regulated programs-whereas ESC maintenance later in adult life may be compensated through yet to be investigated mechanisms.
Mysm1 enhanced function of the IRF2 and IRF8 promoters, suggesting that Mysm1 governs the IRFs for hematopoietic stem cell homeostasis.
MYSM1 activity at the prepro-B cell stage of development is important for the normal programming of B cell responses to stimulation once they complete their maturation process.
Overall we conclude that Mysm1 expression within the niche is not essential for the maintenance of hematopoietic homeostasis.
this study shows that MYSM1 is involved in the maintenance, activation and survival of CD8+ T cells
The results demonstrate that MYSM1 plays a critical role in Mesenchymal Stromal Cell maintenance and differentiation. This study also underscores the biological significance of deubiquitinase activity in Mesenchymal Stromal Cell function.
MYSM1 is a critical negative regulator of p53 transcriptional programs in hematopoiesis, and its repression of Bbc3/PUMA expression is essential for multipotent progenitor survival, and partly contributes to maintaining hematopoietic stem cell function
this study uncovers a critical role for MYSM1 in epigenetically repressing plasma cell differentiation and antibody production, in addition to its opposing, active role in B cell development.
MYSM1 is essential for normal HSC function and progression of hematopoiesis in the fetal liver and HSC maintenance in adult bone marrow.
2 motifs in MYSM1 are essential for innate immune suppression: the SWIRM domain that interacts with TRAF3 and TRAF6 and the metalloproteinase domain that removed K63 polyubiquitins. MYSM1 is a key negative regulator of the innate immune system
Loss of hematopoietic stem cell function and bone marrow failure in Mysm1-knockout mice are the result of p53 activation.
Data indicate that histone H2A deubiquitinase Mysm1 is required for dendritic cell development.
Mysm1-mediated epigenetic regulation has a role in controlling hematopoietic stem cell maintenance, self-renewal, and differentiation
MYSM1 is required for natural killer cell maturation, including the the recruitment of nuclear factor Il-3 to the ID2 locus.
Data indicate a role for histone H2A-deubiquitinase Mysm1 in the maintenance of bone marrow stem cell function, in the control of oxidative stress and genetic stability in hematopoietic progenitors.
MYSM1 derepresses EBF1 transcription in B cell progenitors by orchestrating histone modifications and transcription factor recruitment to the EBF1 locus.
Metalloprotease that specifically deubiquitinates monoubiquitinated histone H2A, a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator. Preferentially deubiquitinates monoubiquitinated H2A in hyperacetylated nucleosomes. Deubiquitination of histone H2A leads to facilitate the phosphorylation and dissociation of histone H1 from the nucleosome. Acts as a coactivator by participating in the initiation and elongation steps of androgen receptor (AR)-induced gene activation (By similarity).
histone H2A deubiquitinase MYSM1
, myb-like, SWIRM and MPN domain-containing protein 1
, Myb-like, SWIRM and MPN domain-containing protein 1